New insight into combatting drug-resistant prostate cancer: New research from the University of Eastern Finland sheds light on the significance of the glucocorticoid receptor in drug-resistant prostate cancer, showing that the development of drug resistance could be prevented by limiting the activity of coregulator proteins. Glucocorticoids regulate vital biological processes by affecting gene encoding through […]
Read More… from New insight into combatting drug-resistant prostate cancer
Gallery of Hope, the exhibition of memories yet to be made, will be launched on 13 March by leading breast cancer research and support charity, Breast Cancer Now, at the Saatchi Gallery and online. Made in collaboration with 10 people living with incurable secondary breast cancer, this exhibition reminds us of the true value of […]
Read More… from Breast Cancer Now creates emotive ‘Gallery of Hope’ powered by AI
A new breast cancer test which may be able to accurately and quickly predict those at risk of their cancer spreading is being trialled at the University of Bradford’s Institute of Cancer Therapeutics. It could mean those at low risk could avoid undergoing gruelling follow-on treatment as well as potentially save the NHS millions of […]
Read More… from New breast cancer test to predict spread of the disease
A new study has discovered a naturally occurring compound found in a fruit has the potential to be an effective alternative treatment for colon cancer. The disease, which affects the large intestine, remains a significant global health concern, ranking as the third most common cancer worldwide. With the alarming projection of 3.2 million new cases […]
Read More… from Natural compound promising new alternative treatment for colon cancer
First UK patients receive experimental mRNA therapy for cancer: Cancer patients in the UK are receiving a new therapeutic to help their bodies recognise and fight cancer cells as part of a global trial. The first UK patients received the experimental mRNA therapy – a type of immunotherapy treatment called mRNA-4359 – at Imperial College […]
Read More… from First UK patients receive experimental mRNA therapy for cancer
Neuroendocrine prostate cancer could be restored to a state that responds to treatment: In the new study researchers at the Ketola Lab discovered a potential new target for drug development in neuroendocrine prostate cancer was discovered. The protein, DPYSL5, is expressed especially in this cancer type and could therefore be a suitable target for drug […]
Read More… from Neuroendocrine prostate cancer treatment responsiveness restoration
While people experiencing homelessness are more exposed to cancer-associated risk factors, there is a lack of awareness and structures for targeted cancer prevention. Yet people experiencing homelessness are twice as likely to be affected by cancer as people who are resident. Against this backdrop, an international team led by Igor Grabovac and Maren Jeleff from […]
Read More… from Improving cancer prevention among people experiencing homelessness
Global cancer burden growing, amidst mounting need for services: Ahead of World Cancer Day, the World Health Organization (WHO)’s cancer agency, the International Agency for Research on Cancer (IARC), released the latest estimates of the global burden of cancer. WHO also published survey results from 115 countries, showing a majority of countries do not adequately […]
Read More… from Global cancer burden growing, amidst mounting need for services
PFAS may increase the risk of disease in unborn children, new study suggests: PFAS are chemicals that may cause cancer, diabetes, and other diseases. Research from Örebro University and the University of Aberdeen now suggests that these chemicals affect people as early as the fetal stage of development. “We see that PFAS likely has a […]
Read More… from PFAS may increase the risk of disease in unborn children
The secret life of CD4+ T cells: from helpers to melanoma fighters: Researchers have revealed unprecedented insights into CD4+ T cells, a type of immune cell, which show promise for immunotherapies against melanoma, the most severe form of skin cancer. In the study led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) […]
Read More… from The secret life of CD4+ T cells: from helpers to melanoma fighters